logo
Plus   Neg
Share
Email

Evonik Q1 Profit Down, Cuts FY20 Forecast; To Pay Dividend - Quick Facts

Specialty chemicals company Evonik Industries AG (EVK.DE) reported Thursday that its first-quarter net income fell 46 percent to 130 million euros from last year's 239 million euros.

Adjusted net income was 181 million euros, or 0.39 euro per share, compared to 249 million euros or 0.53 euro per share a year ago.

Adjusted earnings before interest, tax, depreciation and amortization or EBITDA fell 5 percent from the prior year to 513 million euros. The adjusted EBITDA margin declined to 15.8 percent from 16.4 percent last year.

The company said lower volumes and selling prices were responsible for the decline in adjusted EBITDA in the first quarter.

Sales decreased 1 percent to 3.24 billion euros from 3.29 billion euros last year.

Evonik said it made a solid start to the new year with only 1 drop in sales, despite the economic slowdown caused by the corona pandemic.

Looking ahead for fiscal 2020, Evonik adjusted its outlook, and now expects sales between 11.5 billion euros and 13.0 billion euros and an adjusted EBITDA of between 1.7 billion euros and 2.1 billion euros. Previously, Evonik was expecting stable sales of around 13.1 billion euros and adjusted EBITDA of between 2.1 billion euros and 2.3 billion euros.

Further, the company said its executive board is sticking to its proposal to pay a dividend of 1.15 euros per share for the 2019 financial year. The amount of 0.57 euro per share will be paid on June 2, and the remaining 0.58 euro per share will be paid on September 3.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements. Amid the worsening coronavirus pandemic and mounting costs, banking major Wells Fargo & Co. is preparing to cut thousands of jobs starting later this year, Bloomberg Law reported. Citing people with knowledge of the confidential talks, the report noted that executives are drafting plans that may ultimately eliminate tens of thousands of positions from its about 263,000 workforce. KIND Healthy Snacks is recalling a limited number of Oats & Honey Granola pouches citing the presence of undeclared sesame seeds, the U.S. Food and Drug Administration announced. The recall involves KIND Oats & Honey Granola with Toasted Coconut. Sesame seeds, a known allergen, is not listed as an ingredient in the product, instead, the label lists "sesame seeds" under the "May Contain
RELATED NEWS
Follow RTT